The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust have announced the 2016 class of Pew-Stewart scholars for cancer research.
Five scientists from top research institutions in the United States were selected for their dedication to pursuing innovative leads aimed at finding a cure for cancer. Each will receive 4 years of flexible funding to conduct their work.
“Cancer is a devastating disease, causing pain for millions of patients and their loved ones across the world,” said Rebecca W. Rimel, President and CEO of The Pew Charitable Trusts. “We expect that these scientists and their cutting-edge work will contribute greatly to the fight against this illness.”
Stephanie K. Dougan, PhD
Dirk Hockemeyer, PhD
Paul A. Northcott, PhD
Richard L. Possemato, PhD
Ömer H. Yilmaz, MD, PhD
For 3 years, Pew has partnered with the Alexander and Margaret Stewart Trust to support early-career researchers. The initiative has allowed for the Pew Scholars Program in Biomedical Sciences, a 3-decade-old scholarship program for promising, young scientists, to expand its reach while also supporting an area of great need—cancer research.
“These scientists are truly exceptional—they meet our committee’s expectations for excellence and diligence in every way. Their efforts will be critical to unraveling the mysteries of cancer in the years to come,” said Peter M. Howley, MD, Chair of the Pew-Stewart National Advisory Committee.
The 2016 Pew-Stewart Class
- Stephanie K. Dougan, PhD
Dana-Farber Cancer Institute; Cancer Immunology - Dirk Hockemeyer, PhD
University of California, Berkeley; Molecular Biology - Paul A. Northcott, PhD
St. Jude Children’s Research Hospital; Genetics, Cancer Biology - Richard L. Possemato, PhD
New York University Langone Medical Center; Molecular Biology, Metabolism - Ömer H. Yilmaz, MD, PhD
Massachusetts Institute of Technology; Biology
Visit the program page (pewtrusts.org/en/projects/pew-stewart-scholars-for-cancer-research) to read the scholars’ full abstracts and learn more about the
program. ■
